Citius Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Citius Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Citius Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Citius Pharmaceuticals by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $22k | 28k | 0.78 |
2023-09-30 | $18k | 25k | 0.72 |
2023-06-30 | $59k | 49k | 1.22 |
2023-03-31 | $28k | 24k | 1.19 |
2022-12-31 | $18k | 22k | 0.80 |
2022-03-31 | $37k | 21k | 1.77 |
2021-12-31 | $27k | 18k | 1.53 |
2021-09-30 | $40k | 20k | 2.04 |
2021-06-30 | $66k | 19k | 3.47 |
2021-03-31 | $19k | 10k | 1.83 |
2020-12-31 | $11k | 10k | 1.06 |